Incorporating ovarian cancer ATAC-seq peaks derived from PEO1 cell line49 or CD4+ T cell ATAC-seq peaks did not enhance model accuracy and, in some instances, slightly reduced it (Supplementary Fig. 6e, Supplementary Table 2). This evidence concerns the gene CD4 and ovarian cancer.